Table 3.
In-field relapse (n = 11) | Out-of-field relapse (n = 25) | Total (n = 36) | |
---|---|---|---|
n (%) | n (%) | n (%) | |
Cough | |||
Grade 2 | 0 | 3 (12%) | 3 (8%) |
Grade 3 | 0 | 1 (4%) | 1 (3%) |
Pneumonitis | |||
Grade 2 | 5 (45%) | 6 (24%) | 11 (36%) |
Grade 3 | 0 | 7 (28%) | 7 (28%) |
Esophagitis | |||
Grade 2 | 1 (9%) | 1 (4%) | 2 (6%) |
Grade 3 | 1 (9%) | 2* (8%) | 3 (8%) |
Skin | |||
Grade 2 | 1 (9%) | 0 | 1 (3%) |
Grade 3 | 2 (18%) | 0 | 2 (6%) |
Chest Wall Pain | |||
Not requiring narcotic | 4 (36%) | 1 (4%) | 5 (14%) |
Requiring narcotic | 3 (27%) | 3 (12%) | 6 (17%) |
No Grade 4 or 5 toxicity was seen.
In addition, one patient developed esophageal stricture requiring dilation.